Site Search

Share

X

Search Results

NJ Assembly Financial Institutions & Insurance Committee Votes to Improve Access to Biomarker Testing

Today, the Assembly Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered by New Jersey-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would ...

Florida needs to increase access to game-changing cancer tests

... Cancer Society Cancer Action Network (ACS CAN), we at Florida Cancer Specialists & Research Institute (FCS) are working to improve access to biomarker testing, including innovative diagnostic tests that can provide game-changing information for cancer treatment. Thanks to modern medical breakthroughs, when someone is diagnosed with cancer and when clinically appropriate, we use biomarker testing to precisely identify the mutations unique to a patient’s cancer. Biomarker testing has revolutionized the entire approach to ...

ACS CAN Statement on Nevada Biomarker Legislation

... – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.  The bill was ...

Legislation Introduced to Increase Pennsylvanians’ Access to Biomarker Testing, the Key to Precision Medicine

HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door to targeted therapy and personalized medicine which can improve patient survivorship and quality of life. This is ...

Health Care Providers Call on Governor Hochul to Sign Biomarker Testing Bill without Delay

... gathered today at the Northwell Health Cancer Institute to call on Governor Kathy Hochul to prioritize health equity by improving access to biomarker testing and signing Senate Bill 1196a / Assembly Bill 1673a into law. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...

Legislation Introduced to Increase Californians’ Access to Biomarker Testing, the Key to Precision Medicine

Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced legislation to ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 496 aims to enable more Californians to benefit from biomarker testing, a critical step for accessing precision medicine, including targeted therapies, that can lead to improved survivorship and ...

Governor Signs Legislation Taking First Step to Improving Access to Biomarker Testing for Floridians

TALLAHASSEE, Fla. ‑‑  Gov. Ron DeSantis signed HB885 into law today, which expands patient access to biomarker testing, a key tool used by physicians to identify the most effective treatment of cancer and other diseases. In the case of a cancer diagnosis, biomarker testing allows doctors to develop a personalized treatment plan. It opens the door to the use of targeted therapy, which can result in ...

Biomarker Testing Bill Fails to Advance: Washington Falling Behind in Access to Precision Medicine

... Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not ... “While we are disappointed by the legislature not moving HB 1450 forward, we are determined to keep advocating for patients to have access to biomarker testing and the treatment that is right for them,” said Matt Helder, Washington Government Relations Director. “Washington is known ...

State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments

... here . Sacramento, Calif. –  The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.  Senate Bill 912 would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. The bill moves on to ...

More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing

... implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive  biomarker testing  when supported by medical and scientific evidence. Testing for specific biomarkers – such as gene mutations – found in blood, tissues ... including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing across insurance types is a crucial step to reduce disparities in cancer ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy